Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer

Real-world evidence from clinical practices is fundamental for understanding the efficacy and tolerability of medicinal products. Patients with renal cell cancer were studied to gain data not represented by analyses conducted on highly selected patients participating in clinical trials. Our goal was...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pathol Oncol Res
Asıl Yazarlar: Küronya, Zsófia, Szőnyi, Mihály Dániel, Nagyiványi, Krisztián, Gyergyay, Fruzsina, Géczi, Lajos, Budai, Barna, Martin, Tamás, Ladányi, Andrea, Kiss, Edina, Biró, Krisztina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Netherlands 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471165/
https://ncbi.nlm.nih.gov/pubmed/32572819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-020-00853-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller